| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
Published online before print February 25, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
Laboratory of Biomedical Science, Institute for Medical Research at North Shore-Long Island Jewish System, Manhasset, New York
@ To whom correspondence should be addressed. E-mail: hyang{at}nshs.edu.
 |
Abstract |
|---|
High mobility group box 1 (HMGB1) is a highly conserved, ubiquitous protein present in the nuclei and cytoplasm of nearly all cell types. We recently discovered that HMGB1 is secreted into the extracellular milieu and acts as a proinflammatory cytokine. Administration of HMGB1 to normal animals causes inflammatory responses, including fever, weight loss and anorexia, acute lung injury, epithelial barrier dysfunction, arthritis, and death. Anti-HMGB1 treatment, with antibodies or specific antagonists, rescues mice from lethal endotoxemia or sepsis and ameliorates the severity of collagen-induced arthritis and endotoxin-induced lung injury. Here, we give an abridged review of the cytokine activity of HMGB1, its secretion and release into the extracellular milieu, the putative signal transduction pathways, including interaction with cell-surface receptors and intracellular signaling, and its role in several inflammatory diseases. Finally, the therapeutic potential of blocking HMGB1 in the treatment of inflammatory diseases is discussed.
Key Words: TNF • inflammation • sepsis
This article has been cited by other articles:
|
|
 |
|
  S. M. Rowe, P. L. Jackson, G. Liu, M. Hardison, A. Livraghi, G. M. Solomon, D. B. McQuaid, B. D. Noerager, A. Gaggar, J. P. Clancy, et al. Potential Role of High-Mobility Group Box 1 in Cystic Fibrosis Airway Disease Am. J. Respir. Crit. Care Med., October 15, 2008; 178(8): 822 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-Y. Chou, C.-D. Hsiao, S.-C. Chen, I-W. Chen, S.-T. Liu, and P.-P. Hwang Effects of hypothermia on gene expression in zebrafish gills: upregulation in differentiation and function of ionocytes as compensatory responses J. Exp. Biol., October 1, 2008; 211(19): 3077 - 3084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kitahara, Y. Takeishi, M. Harada, T. Niizeki, S. Suzuki, T. Sasaki, M. Ishino, O. Bilim, O. Nakajima, and I. Kubota High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice Cardiovasc Res, October 1, 2008; 80(1): 40 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Huston, H. Wang, M. Ochani, K. Ochani, M. Rosas-Ballina, M. Gallowitsch-Puerta, M. Ashok, L. Yang, K. J. Tracey, and H. Yang Splenectomy Protects against Sepsis Lethality and Reduces Serum HMGB1 Levels J. Immunol., September 1, 2008; 181(5): 3535 - 3539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Mares, S. S. Ojeda, E. G. Morris, Q. Li, and J. M. Teale Initial Delay in the Immune Response to Francisella tularensis Is Followed by Hypercytokinemia Characteristic of Severe Sepsis and Correlating with Upregulation and Release of Damage-Associated Molecular Patterns Infect. Immun., July 1, 2008; 76(7): 3001 - 3010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zicari, C. Centonze, M. Realacci, B. Buchetti, A. Pietropolli, and C. Ticconi Estradiol 17-{beta} and Progesterone Modulate Inducible Nitric Oxide Synthase and High Mobility Group Box 1 Expression in Human Endometrium Reproductive Sciences, July 1, 2008; 15(6): 559 - 566. [Abstract] [PDF]
|
|
|
|
|
|
Y. Sha, J. Zmijewski, Z. Xu, and E. Abraham HMGB1 Develops Enhanced Proinflammatory Activity by Binding to Cytokines J. Immunol., February 15, 2008; 180(4): 2531 - 2537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Liu, S. Mori, H. K. Takahashi, Y. Tomono, H. Wake, T. Kanke, Y. Sato, N. Hiraga, N. Adachi, T. Yoshino, et al. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats FASEB J, December 1, 2007; 21(14): 3904 - 3916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Barkauskaite, M. Ek, K. Popovic, H.E. Harris, M. Wahren-Herlenius, and F. Nyberg Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus Lupus, October 1, 2007; 16(10): 794 - 802. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Tang, Y. Shi, R. Kang, T. Li, W. Xiao, H. Wang, and X. Xiao Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1 J. Leukoc. Biol., March 1, 2007; 81(3): 741 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-F. Tsan and Baochong Gao Review: Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors Innate Immunity, February 1, 2007; 13(1): 6 - 14. [Abstract] [PDF]
|
|
|
|
|
|
H. Cai, C. Song, I. Endoh, J. Goyette, W. Jessup, S. B. Freedman, H. P. McNeil, and C. L. Geczy Serum Amyloid A Induces Monocyte Tissue Factor J. Immunol., February 1, 2007; 178(3): 1852 - 1860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Foell, H. Wittkowski, T. Vogl, and J. Roth S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules J. Leukoc. Biol., January 1, 2007; 81(1): 28 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. E. Dumitriu, M. E. Bianchi, M. Bacci, A. A. Manfredi, and P. Rovere-Querini The secretion of HMGB1 is required for the migration of maturing dendritic cells J. Leukoc. Biol., January 1, 2007; 81(1): 84 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Bell, W. Jiang, C. F. Reich III, and D. S. Pisetsky The extracellular release of HMGB1 during apoptotic cell death Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1318 - C1325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Birkenmeier, S. Nicklisch, C. Pockelt, A. Mossie, V. Steger, C. Glaser, S. Hauschildt, E. Usbeck, K. Huse, U. Sack, et al. Polymyxin B-Conjugated {alpha}2-Macroglobulin as an Adjunctive Therapy to Sepsis: Modes of Action and Impact on Lethality J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 762 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Qin, H. Wang, R. Yuan, H. Li, M. Ochani, K. Ochani, M. Rosas-Ballina, C. J. Czura, J. M. Huston, E. Miller, et al. Role of HMGB1 in apoptosis-mediated sepsis lethality J. Exp. Med., July 10, 2006; 203(7): 1637 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mitola, M. Belleri, C. Urbinati, D. Coltrini, B. Sparatore, M. Pedrazzi, E. Melloni, and M. Presta Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine J. Immunol., January 1, 2006; 176(1): 12 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Lee, H. S. Jung, P. M. Giang, X. Jin, S. Lee, P. T. Son, D. Lee, Y.-S. Hong, K. Lee, and J. J. Lee Blockade of Nuclear Factor-{kappa}B Signaling Pathway and Anti-Inflammatory Activity of Cardamomin, a Chalcone Analog from Alpinia conchigera J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 271 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bandhuvula, Y. Y. Tam, B. Oskouian, and J. D. Saba The Immune Modulator FTY720 Inhibits Sphingosine-1-phosphate Lyase Activity J. Biol. Chem., October 7, 2005; 280(40): 33697 - 33700. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
